Clinical trial
Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)
NCT00423280 · University of Oxford, Other · Unknown status
Key facts
| NCT number | NCT00423280 |
|---|---|
| Title | Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study) |
| Official title | A Randomised, Placebo-Controlled Study of Two Doses of Oral 6R-BH4 on Vascular Function in Subjects With Coronary Artery Disease |
| Lead sponsor | University of Oxford, Other |
| Collaborators | BioMarin Pharmaceutical Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | 6R-BH4 |
| Enrollment | 66 |
| Start date | Nov 1, 2006 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Jan 18, 2007 |
| Last update posted | Aug 7, 2008 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: